The ratings on Wilmington, Del.-based E.I. DuPont De Nemours&Co. reflect its excellent business risk profile as one of the world's premier chemical, specialty materials, and seed producers, with trailing 12-month sales of nearly $30 billion, and an intermediate financial risk profile. DuPont's key business strengths include leading technology and cost positions in an exceptionally broad mix of products and geographic markets, with more than 60% of sales outside the U.S., including a significant portion in emerging markets that offer long-term growth potential. DuPont's key business segments include agriculture and nutrition, coatings and color technologies, electronic and communication technologies, performance materials, and safety and protection. In addition, DuPont receives royalty payments from Merck&Co. Inc. for the hypertension
